Australian Professional Services Stock News

Key Insights Given the large stake in the stock by institutions, GrainCorp's stock price might be vulnerable to their...

Regis Healthcare Limited ( ASX:REG ) shareholders won't be pleased to see that the share price has had a very rough...

It's been a soft week for Baby Bunting Group Limited ( ASX:BBN ) shares, which are down 13%. But looking back over the...

Key Insights Institutions' substantial holdings in Select Harvests implies that they have significant influence over...

The Medical Developments International Limited ( ASX:MVP ) share price has done very well over the last month, posting...

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...

The Aerometrex Limited ( ASX:AMX ) share price has done very well over the last month, posting an excellent gain of...

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...

The Australian stock market has shown resilience, with the ASX200 up 10% over the past ten months, despite a quiet September. As critical minerals and healthcare sectors gain momentum amid geopolitical shifts, investors are increasingly looking at growth companies with high insider ownership as potential opportunities.

The Australian stock market has shown resilience, with the ASX200 gaining 10% over the past ten months, despite a relatively uneventful September. Recent developments in critical minerals and healthcare have sparked investor interest, highlighting opportunities for stocks priced below their intrinsic value estimates. In this context, identifying undervalued stocks requires a keen understanding of market trends and potential catalysts like geopolitical shifts or sector-specific growth drivers.

The Australian market has shown resilience, with the ASX200 climbing 10% over the past ten months, driven in part by renewed interest in critical minerals as geopolitical tensions influence global supply dynamics. In this environment, identifying stocks with strong fundamentals and strategic positioning in emerging sectors like rare earths and healthcare can offer intriguing opportunities for investors seeking to navigate these evolving market conditions.

The Australian market has seen a steady rise, with the ASX200 up 10% over the past ten months, driven in part by renewed interest in critical minerals due to geopolitical tensions. While penny stocks might sound like a term from trading days gone by, they still represent an intriguing segment for investors seeking growth opportunities. These smaller or newer companies can offer significant potential when backed by solid financials, and this article highlights three such stocks that could...

Australian Foundation Investment Company Limited recently updated its ongoing share buy-back program, repurchasing 370,489 shares and bringing the total bought back to over 11 million to date. This reduction in outstanding shares aims to enhance shareholder value and underscores the company's commitment to its income-focused strategy. We'll explore how this ongoing buy-back initiative bolsters Australian Foundation Investment's appeal for income-oriented investors. Find companies with...

West African Resources (ASX:WAF) has caught attention after bringing its Keaca mine online earlier than expected and under budget. Management followed up with plans to ramp up production and to update long-term reserves soon. See our latest analysis for West African Resources. With Keaca now up and running ahead of schedule, market interest has shifted from uncertainty to optimism, and it shows. West African Resources has seen a 31.6% share price return over the past 90 days and an impressive...

On October 1, 2025, Mesoblast Limited announced that a permanent Medicare HCPCS J-Code (J3402) for Ryoncil® (remestemcel-L-rknd) became active, providing a standardized billing pathway for this FDA-approved therapy in pediatric steroid-refractory acute graft-versus-host disease. This CMS formal recognition is expected to simplify reimbursement and potentially broaden both public and private payer access to the only mesenchymal stromal cell product approved for children under age 12 with this...

Sun Silver held a briefing on its Maverick Springs Project as part of Australia's critical minerals engagement with the U.S., coinciding with the upcoming summit between Prime Minister Anthony Albanese and President Donald Trump scheduled for October 20. This alignment places Sun Silver at the center of international discussions on mineral supply chains and highlights its potential relevance to global resource policy. We'll explore how inclusion in Australia-U.S. critical minerals talks may...

CBOE Australia winning approval to list companies marks a turning point for the Australian market. This move directly challenges ASX (ASX:ASX)'s decades-long leadership in equity listings and sets the stage for deeper competition and innovation. See our latest analysis for ASX. ASX shares have been under pressure in 2025, with the stock recording a year-to-date share price decline of 11.3% and a 1-year total shareholder return of -10.1%. This reflects market caution even as big changes...

Anticipation is building around AIC Mines (ASX:A1M) as the company confirmed it will release its Q1 2026 final results before the market opens on October 16, 2025. Investors know that earnings updates can reveal key financial and operational trends. See our latest analysis for AIC Mines. Recent momentum around AIC Mines stands out, with a 31.8% one-month share price return and a 35.9% gain over the last 90 days, suggesting growing optimism. Although long-term total returns are still catching...

Evolution Mining (ASX:EVN) has caught investors’ attention lately, thanks to fresh coverage highlighting the company’s steady operational performance, healthy dividend track record, and disciplined reinvestment decisions over the past year. See our latest analysis for Evolution Mining. Momentum has been building for Evolution Mining, with a 30-day share price return of 15.35% and a remarkable year-to-date jump of 135.95%. The company’s 1-year total shareholder return stands at an impressive...

In October 2025, Dicker Data confirmed it had suspended its former CEO, David Dicker, following a whistleblower complaint regarding his alleged treatment of an executive. The company emphasized that daily operations and senior management continuity were maintained, illustrating organizational stability despite a high-profile leadership incident. We'll examine how the CEO suspension shapes investor sentiment and Dicker Data's ongoing commitment to operational stability. The end of cancer?...

St George Mining announced in recent days that it has secured A$72.5 million through a major follow-on equity offering to fund the advancement of its Araxá rare earths-niobium project in Brazil, with substantial support from Hancock Prospecting and other institutional investors. This capital infusion highlights the growing global importance of non-Chinese supply chains for critical minerals vital to technology, renewable energy, and defense sectors. We will examine how Hancock Prospecting's...

Key Insights APA Group's Annual General Meeting to take place on 22nd of October CEO Adam Watson's total compensation...

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...

The Bank of Queensland (ASX:BOQ) released its full-year results, showing net income and earnings per share down from last year. This earnings announcement comes just before the bank’s upcoming quarterly call, drawing close investor focus. See our latest analysis for Bank of Queensland. Shares of Bank of Queensland have seen some ups and downs lately, with a mild 1-month share price return of 0.6% but a steeper 8.1% decline over the past three months as the market digested weaker earnings...